Oniria Therapeutics — Seed · €1.28M

Oniria Therapeutics, a 2021 spin-off of the Vall d'Hebron Institute of Oncology developing ONR-001 to eliminate persistent tumour cells that drive relapse, closed a €1.28 million seed round led by Fundación Botín's Mind the Gap programme. Banco Sabadell's BStartup, business angels and public instruments (ACCIÓ Startup Capital, Torres Quevedo, AGAUR Investigo) also participated, funding regulatory preclinical work into early 2024.